Foghorn Therapeutics Inc (FHTX)

Nov 29, 2024

How the (FHTX) price action is used to our Advantage - Stock Traders Daily

Nov 29, 2024

Nov 29, 2024

Foghorn Therapeutics (FHTX) Upgraded to Buy: Here's Why - Yahoo Finance

Nov 29, 2024

Nov 26, 2024

Wall Street Analysts See a 104.08% Upside in Foghorn Therapeutics (FHTX): Can the Stock Really Move This High? - MSN

Nov 26, 2024

Nov 19, 2024

(FHTX) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 19, 2024

Nov 18, 2024

Foghorn Therapeutics patents new CBP degradation inducers - BioWorld Online

Nov 18, 2024

Nov 13, 2024

Foghorn Therapeutics (FHTX) Collaborates with Eli Lilly and Surpasses Q3 Expectations - Nasdaq

Nov 13, 2024

Nov 12, 2024

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences - The Manila Times

Nov 12, 2024

Nov 08, 2024

(FHTX) Trading Report - Stock Traders Daily

Nov 08, 2024

Nov 08, 2024

What is HC Wainwright’s Estimate for FHTX FY2024 Earnings? - Defense World

Nov 08, 2024

Nov 08, 2024

Wedbush Lifts Earnings Estimates for Foghorn Therapeutics - Defense World

Nov 08, 2024

Nov 07, 2024

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Simply Wall St

Nov 07, 2024

Nov 07, 2024

Analysts Have Made A Financial Statement On Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) Third-Quarter Report - Yahoo Finance

Nov 07, 2024

Nov 07, 2024

Research Analysts Issue Forecasts for FHTX FY2024 Earnings - MarketBeat

Nov 07, 2024

Nov 07, 2024

HC Wainwright Has Bullish Estimate for FHTX FY2024 Earnings - MarketBeat

Nov 07, 2024

Nov 06, 2024

We Think Foghorn Therapeutics (NASDAQ:FHTX) Needs To Drive Business Growth Carefully - Yahoo Finance

Nov 06, 2024

Nov 06, 2024

Foghorn Therapeutics Inc (FHTX) Q3 2024 Earnings: Revenue Surpas - GuruFocus.com

Nov 06, 2024

Nov 06, 2024

Foghorn Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 06, 2024

Nov 05, 2024

Foghorn Therapeutics Inc. (FHTX) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 05, 2024

Nov 04, 2024

Foghorn Therapeutics Reports Third Quarter Highlights - TipRanks

Nov 04, 2024

Nov 04, 2024

Foghorn Therapeutics Provides Third Quarter 2024 Financial and Corporate Update - GlobeNewswire

Nov 04, 2024

Nov 04, 2024

Foghorn Therapeutics Advances Oncology Pipeline with New Trials - TipRanks

Nov 04, 2024

Oct 27, 2024

(FHTX) Investment Report - Stock Traders Daily

Oct 27, 2024

Oct 26, 2024

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Shares Sold by Raymond James & Associates - Defense World

Oct 26, 2024

Oct 22, 2024

Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) 28% Share Price Plunge Could Signal Some Risk - Simply Wall St

Oct 22, 2024

Oct 17, 2024

Short Interest in Foghorn Therapeutics Inc. (NASDAQ:FHTX) Increases By 9.1% - MarketBeat

Oct 17, 2024

Oct 16, 2024

Long Term Trading Analysis for (FHTX) - Stock Traders Daily

Oct 16, 2024

Oct 11, 2024

Foghorn Therapeutics Unveils Clinical Pipeline Progress - Yahoo Finance

Oct 11, 2024

Oct 10, 2024

Foghorn Therapeutics Announces First Patient Dosed with - GlobeNewswire

Oct 10, 2024

Oct 10, 2024

Foghorn Therapeutics Announces First Patient Dosed with First-in-Class Oral SMARCA2 Selective Inhibitor FHD-909 in a Phase 1 Trial for SMARCA4 Mutated Solid Tumors - The Manila Times

Oct 10, 2024

Oct 10, 2024

Foghorn Therapeutics Announces First Patient Dosed with First-in-Class Oral SMARCA2 Selective - The Bakersfield Californian

Oct 10, 2024

Oct 09, 2024

FHTXFoghorn Therapeutics Inc. Latest Stock News & Market Updates - StockTitan

Oct 09, 2024

Oct 07, 2024

BeiGene (BGNE) Moves 5.3% Higher: Will This Strength Last? - Yahoo Finance

Oct 07, 2024

Oct 01, 2024

Foghorn Therapeutics to Participate in the BMO Oncology Summit - GlobeNewswire

Oct 01, 2024

Sep 30, 2024

Perceptive Advisors LLC Purchases Shares of 544,000 Foghorn Therapeutics Inc. (NASDAQ:FHTX) - Defense World

Sep 30, 2024

Sep 30, 2024

Perceptive Advisors LLC Buys New Position in Foghorn Therapeutics Inc. (NASDAQ:FHTX) - MarketBeat

Sep 30, 2024

Sep 30, 2024

Foghorn Therapeutics' SWOT analysis: chromatin biology pioneer's stock outlook By Investing.com - Investing.com UK

Sep 30, 2024

Sep 29, 2024

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Stock Holdings Increased by Rhumbline Advisers - Defense World

Sep 29, 2024

Sep 26, 2024

Deerfield Management Company L.P. Series C Takes Position in Foghorn Therapeutics Inc. (NASDAQ:FHTX) - MarketBeat

Sep 26, 2024

Sep 26, 2024

Deerfield Management Company L.P. Series C Purchases Shares of 2,518,500 Foghorn Therapeutics Inc. (NASDAQ:FHTX) - Defense World

Sep 26, 2024

Sep 25, 2024

Foghorn Therapeutics exec sells over $360k in company stock By Investing.com - Investing.com South Africa

Sep 25, 2024

Sep 25, 2024

Bank of New York Mellon Corp Buys 18,664 Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX) - Defense World

Sep 25, 2024

Sep 25, 2024

Foghorn Therapeutics exec sells over $360k in company stock - Investing.com India

Sep 25, 2024

Sep 25, 2024

(FHTX) Long Term Investment Analysis - Stock Traders Daily

Sep 25, 2024

Sep 24, 2024

Foghorn Therapeutics (FHTX) Stock Forecast and Price Target 2024 - MarketBeat

Sep 24, 2024

Sep 24, 2024

Optimism Grows in the Fight Against Cancer as Breakthroughs and Funding Increase - Benzinga

Sep 24, 2024

Sep 24, 2024

Foghorn Therapeutics (NASDAQ:FHTX) Price Target Raised to $9.00 - MarketBeat

Sep 24, 2024

Sep 23, 2024

Market Insight: Foghorn Therapeutics Inc (FHTX)’s Notable Gain, Closing at 9.99 - The Dwinnex

Sep 23, 2024

Sep 21, 2024

Foghorn Therapeutics exec sells over $116k in company stock By Investing.com - Investing.com Australia

Sep 21, 2024

Sep 20, 2024

Foghorn Therapeutics exec sells over $116k in company stock - Investing.com India

Sep 20, 2024